E-LIB Suche - Ergebnisse für: Usenko, Ganna

1

PORT: A Randomized, Cross-Over, Phase 2 Study of Melflufen ..:

Pour, Ludek ; Micheva, Ilina ; Usenko, Ganna...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. e267-e275.e2 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and safety of melflufen plus daratumumab and dexam..:

Pour, Luděk ; Szarejko, Monika ; Bila, Jelena...
Haematologica. 109 (2023) 3 - p. 895-905 , 2023

Link: https://doi.org/10.3324/..

3

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Małgorzata...
HemaSphere. 6 (2022) 12 - p. e801 , 2022

Link: https://doi.org/10.1097/..

4

Radiological Findings on Chest Computed Tomography in Patie..:

Usenko, Ganna ; Gashynova, Kateryna
Cureus. , 2022

Link: https://doi.org/10.7759/..

5

Health-related quality of life in patients with newly diagn..:

Knop, Stefan ; Mateos, Maria-Victoria ; Dimopoulos, Meletios A....
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

6

Peripheral neuropathy symptoms, pain, and functioning in pr..:

Sanchez, Larysa ; Leleu, Xavier ; Beaumont, Jennifer L....
American Journal of Hematology. 96 (2021) 10 - p. , 2021

Link: https://doi.org/10.1002/..

7

P-205: PORT (OP-109): Phase 2, randomised, Pharmacokinetic ..:

Minarik, Jiri ; Micheva, Ilina ; Usenko, Ganna...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S151-S152 , 2021

Link: https://doi.org/10.1016/..

8

Selinexor, bortezomib, and dexamethasone versus bortezomib ..:

Richard, Shambavi ; Chari, Ajai ; Delimpasi, Sosana...
American Journal of Hematology. 96 (2021) 9 - p. 1120-1130 , 2021

Link: https://doi.org/10.1002/..

9

Effect of prior treatments on selinexor, bortezomib, and de..:

Mateos, Maria V. ; Gavriatopoulou, Maria ; Facon, Thierry...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

10

Effect of age and frailty on the efficacy and tolerability ..:

Auner, Holger W. ; Gavriatopoulou, Maria ; Delimpasi, Sosana...
American Journal of Hematology. 96 (2021) 6 - p. 708-718 , 2021

Link: https://doi.org/10.1002/..

11

Once-per-week selinexor, bortezomib, and dexamethasone vers..:

Grosicki, Sebastian ; Simonova, Maryana ; Spicka, Ivan...
The Lancet. 396 (2020) 10262 - p. 1563-1573 , 2020

Link: https://doi.org/10.1016/..

12

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Malgorzata...
HemaSphere. -6 : 12 (2022), p. 1-10. -Hemasphere. - 2572-9241. , 2022

Link: https://hdl.handle.net/2..

13

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Małgorzata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666115/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Effect of prior treatments on selinexor, bortezomib, and de..:

Mateos, Maria V ; Gavriatopoulou, Maria ; Facon, Thierry...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045319/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Health-related quality of life in patients with newly diagn..:

Knop, Stefan ; Mateos, Maria-Victoria ; Dimopoulos, Meletios A...
boreal:247981. , 2021

Link: http://hdl.handle.net/20..